Status | Study |
Not yet recruiting |
Study Name: Secukinumab Safety and Efficacy in JPsA and ERA Condition: Juvenile Psoriatic Arthritis Enthesitis-related Arthritis Date: 2016-11-02 Interventions: Drug: AIN457 Secukinumab (AIN4 |
Recruiting |
Study Name: Juvenile Arthritis Quantitative Imaging Condition: Arthritis, Juvenile Idiopathic Enthesitis-Related Arthritis, Ju Date: 2016-02-10 Interventions: Other: MRI scan (adolescent spine protocol) |
Recruiting |
Study Name: Observational Study of Pediatric Rheumatic Diseases: The CARRA Registry Condition: Rheumatic Joint Disease Date: 2015-04-13 |
Active, not recruiting |
Study Name: Pediatric Arthritis Study of Certolizumab Pegol Condition: Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Date: 2012-03-07 Interventions: Drug: Certolizumab Pegol (CZP) CZP will be administered su |
Recruiting |
Study Name: Natural History and Development of Spondyloarthritis Condition: Arthritis Spondylitis, Ankylosing Date: 2011-08-23 |
Active, not recruiting |
Study Name: Extension Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis Condition: Juvenile Idiopahtic Arthritis Date: 2011-08-18 Interventions: Drug: etanercept Subjects aged <18 years and less than |
Completed |
Study Name: A Study of the Efficacy and Safety of Adalimumab in Pediatric Subjects With Enthesitis Related Arthritis Condition: Enthesitis Related Arthritis (ERA) Date: 2010-07-19 Interventions: Biological: adalimumab Adalimu |
Completed |
Study Name: Study Evaluating Etanercept in 3 Subtypes of Childhood Arthritis Condition: Arthritis, Juvenile Idiopathic Date: 2009-08-13 Interventions: Drug: Etanercept Etanercept 0.8 mg/kg QW up to a maximum dose of 50 mg |